Next Article in Journal
Structural Biology of DNA (6-4) Photoproducts Formed by Ultraviolet Radiation and Interactions with Their Binding Proteins
Previous Article in Journal
Nrf2 and Redox Status in Prediabetic and Diabetic Patients
Article Menu
Issue 11 (November) cover image

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2014, 15(11), 20306-20320; doi:10.3390/ijms151120306

Post-Transcriptional Up-Regulation of PDGF-C by HuR in Advanced and Stressed Breast Cancer

Department of General Surgery, Tangdu Hospital, Fourth Military Medical University, Xi'an 710032, China
Department of General Surgery, 10 Hospital of People's Liberation Army (PLA), Wuwei 733000, China
Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an 710032, China
These authors contributed equally to this work.
Authors to whom correspondence should be addressed.
Received: 11 August 2014 / Revised: 16 October 2014 / Accepted: 28 October 2014 / Published: 6 November 2014
(This article belongs to the Section Biochemistry, Molecular and Cellular Biology)
View Full-Text   |   Download PDF [1879 KB, uploaded 6 November 2014]   |  


Breast cancer is a heterogeneous disease characterized by multiple genetic alterations leading to the activation of growth factor signaling pathways that promote cell proliferation. Platelet-derived growth factor-C (PDGF-C) is overexpressed in various malignancies; however, the involvement of PDGF-C in breast cancers and the mechanisms underlying PDGF-C deregulation remain unclear. Here, we show that PDGF-C is overexpressed in clinical breast cancers and correlates with poor prognosis. PDGF-C up-regulation was mediated by the human embryonic lethal abnormal vision-like protein HuR, which stabilizes the PDGF-C transcript by binding to two predicted AU-rich elements (AREs) in the 3'-untranslated region (3'-UTR). HuR is up-regulated in hydrogen peroxide-treated or ultraviolet-irradiated breast cancer cells. Clinically, HuR levels are correlated with PDGF-C expression and histological grade or pathological tumor-node-metastasis (pTNM) stage. Our findings reveal a novel mechanism underlying HuR-mediated breast cancer progression, and suggest that HuR and PDGF-C are potential molecular candidates for targeted therapy of breast cancers. View Full-Text
Keywords: breast neoplasms; HuR; mRNA stability; platelet-derived growth factor-C (PDGF-C) breast neoplasms; HuR; mRNA stability; platelet-derived growth factor-C (PDGF-C)

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Luo, N.-A.; Qu, Y.-Q.; Yang, G.-D.; Wang, T.; Li, R.-L.; Jia, L.-T.; Dong, R. Post-Transcriptional Up-Regulation of PDGF-C by HuR in Advanced and Stressed Breast Cancer. Int. J. Mol. Sci. 2014, 15, 20306-20320.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top